In this issue:
- Dementia risk after SGLT-2 or DPP-4 inhibitor initiation in type 2 diabetes
- Psychiatric safety of semaglutide for weight management
- Real-world weight reduction with semaglutide or liraglutide
- General and abdominal adiposity and hypertension across eight world regions
- Impact of SGLT-2 inhibitors and GLP-1 agonists on insulin utilisation and costs
- Relationship between social determinants and diabetes prevalence
- Impact of physical activity on the relationship between sitting time and mortality
- Impact of BMI and excessive gestational weight gain on pregnancy outcomes in type 1 diabetes
- Whole-food, plant-based lifestyle for type 2 diabetes
- Early findings from the UK NHS Type 2 Diabetes Path to Remission programme
Please login below to download this issue (PDF)